MedicarePartD.guide

A non-government resource built from CMS public data

IL-17, IL-23 and IL-12/23 biologics on every 2026 Puerto Rico Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
IL-17, IL-23 and IL-12/23 biologics by 2026 Puerto Rico Part D plan
DrugHealthSpring Extra Rx$50.00/moS5617-385HealthSpring Assurance Rx$65.70/moS5617-348AARP Medicare Rx Preferred from UHC$145.10/moS5820-037
StelaraustekinumabTier 5PA25%QL 0.5/28dTier 5PA25%QL 0.5/28dNot covered
ustekinumab biosimilarsWezlana, Selarsdi, Pyzchiva and othersTier 5PA25%QL 0.5/28dTier 5PA25%QL 0.5/28dNot covered
Wezlanaustekinumab-auubNot coveredNot coveredNot covered
Selarsdiustekinumab-aeknTier 3PA17%QL 0.5/28dTier 3PA22%QL 0.5/28dNot covered
SkyrizirisankizumabTier 5PA25%QL 2/28dTier 5PA25%QL 2/28dTier 5PA25%QL 1/28d
TremfyaguselkumabTier 5PA25%QL 2/28dTier 5PA25%QL 2/28dTier 5PA25%
CosentyxsecukinumabTier 5PA25%QL 10/28dTier 5PA25%QL 10/28dTier 5PA25%QL 10/30d
TaltzixekizumabNot coveredNot coveredNot covered
BimzelxbimekizumabNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.